Flash glucose monitoring in the practice of pediatric endocrinologist

• Goar F. Okminyan
• Elena V. Kiseleva
• Oleg Yu. Latyshev
• Elvira P. Kasatkina
• Lyubov’ N. Samsonova

Abstract

Continuous glucose monitoring technologies are rapidly gaining positions in pediatric endocrinology practice: according to foreign authors, the number of children using continuous glucose monitoring (CGM) technologies increased 10-fold from 2016 to 2018. In the Russian Federation, the study of blood glucose levels by continuous monitoring is regulated by the clinical recommendations «Type 1 diabetes in children», moreover, the method of CGM is included to the updated standard of medical care for children with type 1 diabetes (diagnosis and treatment) in 2021. As the use of CGM devices continues to expand rapidly, the effective integration of this method into clinical practice will become a central element of ensuring optimal childcare facilities and teenagers with type 1 diabetes.

Keywords:continuous glucose monitoring, Flash glucose monitoring, FreeStyle Libre, analysis of the outpatient glycemic profile, hypoglycemia, insulin therapy

REFERENCES

1. International Diabetes Federation. IDF Diabetes Atlas, 9^th Edition, 2019. https://www.diabetesatlas.org/en/ (date of acces: 27.07.2020)

2. Federal Register of Patients with Diabetes Mellitus. http://www.diar-egistry.ru (in Russian)

3. DiMeglio L.A., Acerini C.L., Codner E., Craig M.E., Hofer S.E., Pillay K., et al. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018; 19 Suppl 27: 105-14. DOI: https://doi.org/10.1111/pedi.12737 PMID: 30058221.

4. Redondo M.J., Libman I., Maahs D.M., Lyons S.K., Saraco M., Reusch J., et al. The evolution of hemoglobin A1c targets for youth with type 1 diabetes: rationale and supporting evidence. Diabetes Care. 2021; 44 (2): 301-12. DOI: https://doi.org/10.2337/dc20-1978 PMID: 33431422; PMCID: PMC 7818324.

5. Dovc K., Battelino T. Time in range centered diabetes care. Clin Pediatr Endocrinol. 2021;30 (1):1-10. DOI: https://doi.org/10.1297/ cpe.30.1 PMID: 33446946; PMCID: PMC 7783127.

6. Type 1 diabetes mellitus in children. Clinical guidelines. https://rae-org.ru/system/files/documents/pdf/klinicheskie_rekomendacii_sd1_deti_2021_4.pdf (in Russian)

7. Laffel L.M., Kanapka L.G., Beck R.W., Bergamo K., Clements M.A., Criego A., et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: A randomized clinical trial. JAMA. 2020; 323 (23): 2388-96. DOI: https://doi.org/10.1001/jama.2020.6940 PMID: 32543683; PMCID: PMC 7298603.

8. Foster N.C., Beck R.W., Miller K.M., Clements M.A., Rickels M.R., DiMeglio L.A., et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther 2019; 21 (2): 66-72. DOI: https://doi.org/10.1089/dia.2018.0384

9. Battelino T., Danne T., Bergenstal R.M., Amiel S.A., Beck R., Biester T., et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care. 2019; 42 (8): 1593-603. DOI: https://doi.org/10.2337/dci19-0028 PMID: 31177185; PMCID: PMC 6973648.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)